JOIN US FOR ANOTHER ENGAGING AAPS Open Scientific Discussion (OSD)!
TOPIC: CAR-T: Preclinical Assessment of Potential for Secondary Malignancies
Co-sponsored by the GCTP and BPM Communities
📅 Date: Monday, June 16, 2025
🕛 Time: 12:00 PM – 1:00 PM Eastern Time
📍 Location: Virtual Seminar @ https://global.gotomeeting.com/join/271724949
OSD OVERVIEW
Join us for an engaging 1-hour discussion featuring:
Dr. Gabriela Hernandez Hoyos (BMS) and Dr. Ilayaraja Muthuramu (J&J)
Experts in genomic risk analysis and safety assessments of CAR T platforms
They will explore:
- Genomic risks in lentiviral vs. gene-edited CAR T products
- Key molecular and functional assays used in risk assessment
- Preclinical safety challenges in autologous vs. allogeneic approaches
- Insights from published case studies and FDA-approved testing strategies
WHO SHOULD ATTEND?
Scientists, researchers, and professionals working in:
- Gene and cell therapy
- Regulatory science
- Oncology R&D
- Translational medicine
WHY ATTEND?
- Hear from leaders in the field
- Participate in an open discussion on safety assessment strategies
- Gain insights into regulatory and translational approaches for CAR T therapies
ADD TO YOUR CALENDAR NOW AND SHARE WITH COLLEAGUES!
Look for this event on AAPS Communities and LinkedIn soon.
------------------------------
Dale Miles
Distinguished Scientist, Clinical Pharmacology
Genentech
South San Francisco CA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------